karen frank american clinical pathologist microbiologist researching pathogenesis staphylococcus aureus pneumonia resistant gramnegative bacteria senior clinician principal investigator chief laboratory medicine national institutes health clinical center frank completed md phd biochemistry university pennsylvania completed clinical pathology residency brigham womens hospital postdoctoral research fellowship immunology focused vdj recombination developing lymphocytes howard hughes medical institute laboratory frederick alt boston childrens hospital faculty member studies included dna repair mechanisms relevant cancer immunology followed microbiological investigations staphylococcus aureus frank served director lab service center phlebotomy associate director pathology residency program served consultant medical student education clinical algorithms bacterial antibiotic resistance testing laboratories two hospitals china part wuhan medical education reform project frank boardcertified clinical pathologist years experience clinical microbiologist seven years experience director clinical microbiology immunology laboratories frank joined department laboratory medicine national institutes health clinical center senior clinician principal investigator chief laboratory medicine clinical center frank chairs resident inservice exam committee american society clinical pathology presidentelect academy clinical laboratory physicians scientists director accreditation council graduate medical educationaccredited clinical microbiology franks laboratory projects include evaluation malditof identification microorganisms molecular methods microbial franks research collaboration juliane bubeck wardenburg departments pediatrics microbiology university chicago focused pathogenesis staphylococcus aureus pneumonia using microarray analysis murine lung rna examined response host virulent staphylococcal strain compared strain deficient alphatoxin determined cellular immune response infection characterized prominent response wildtype pathogen investigation hostpathogen interaction pathogenesis staphylococcal lung injury contribute programs aimed development novel therapeutic approaches staphylococcal investigators national human genome research institute nih clinical center used advanced dna sequencing methods characterize carbapenemresistant enterobacteriaceae hospitalized patients tracked cluster infections hospitalized patients recently franks laboratory conducted twoyear followup study understand possible spread resistant genes bacteria investigate mechanisms used bacteria spread resistance franks research program examined frequency horizontal gene transfer among species using bacterial isolates two hospitals conjugation studies use lab strain e coli typically narrow conditions given conjugation influenced multiple factors sought perform systematic analysis blakpc encoding plasmids transfer multiple species efficiency conjugation enterobacteriaceae patient isolates common lab cloning e coli strain ranged widely high rates cfu transconjugantscfu recipients undetectable without clear correlation pattern spread suggested two hospital outbreaks vitro models may faithfully predict plasmid mobilization better understand important variables affecting conjugation httpsenwikipediaorgwikikarenmfrank